Eli Lilly and Company
CorpDigest
Eli Lilly and Company
Annual Revenue
Last reviewed: 2026-06-03 · By Swet Parvadiya
FY2022 Revenue
$28.5B
▲ 0.8% vs FY2021 ($28.3B)
Eli Lilly and Company reported $28.5B in revenue for fiscal year 2022. This represents a growth of 0.8% compared to the 2021 figure of $28.3B. In 2023, revenue increased to $34.1B.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $45.0B | $10.6B | +31.9% |
| FY2023 | $34.1B | — | +19.6% |
| FY2022 | $28.5B | — | +0.8% |
| FY2021 | $28.3B | — | +15.5% |
| FY2020 | $24.5B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.